Camila Canaán-Haden | Biomedical research | Best Researcher Award

Posted on by ScienceFather

Ms. Camila Canaán-Haden | Biomedical research | Best Researcher Award

PhD student, Center for Genetic Engineering and Biotechnology (CIGB)

Camila Canaán-Haden Ayala is a Cuban researcher specializing in cancer immunotherapy. She works at the Center for Genetic Engineering and Biotechnology (CIGB), focusing on developing therapeutic cancer vaccines and recombinant antigen production. Her expertise includes immune response evaluations using ELISA, FACS, ELISPOT, and cytokine assays in various models. She has contributed to COVID-19 clinical trials and vaccine development, including the Abdala vaccine. Camila has undertaken multiple international research fellowships in Italy, Spain, France, and Mexico. Her work aims to improve immunotherapeutic strategies against cancer by targeting immune checkpoints and optimizing vaccine efficacy.

Profile

Scholar

🎓 Education

Camila holds a Master’s in Contemporary Biotechnology (2019-2022) from CIGB and a Bachelor’s in Biochemistry and Molecular Biology (2012-2017) from the University of Havana. She completed postgraduate training in bioinformatics, immunology, protein engineering, and good laboratory practices. Her academic foundation includes mathematics, chemistry, molecular genetics, virology, and clinical biochemistry. She has pursued advanced studies in biomedical research through multiple international pre-doctoral fellowships.

💼 Experience

Since 2017, Camila has been a researcher at CIGB’s Cancer Immunotherapy Lab. She has led projects on immune checkpoint inhibition strategies and therapeutic cancer vaccine development. Her work includes antigen cloning, protein characterization, and immunogenicity studies in animal models. She has evaluated antitumor and anti-metastatic effects of novel therapies and contributed to clinical trials for COVID-19 treatments. She has also worked with antibody phage display libraries to develop scFv antibodies. Her research extends to immune response assessments for cancer and infectious disease vaccines.

🏆 Awards & Honors

Camila has received prestigious short-term pre-doctoral fellowships in Italy (ICGEB-Trieste, University of Padua), Spain (CIBIR), France (Cancer Research Center of Lyon), and Mexico (CICESE), funded by international programs like IILA, Coimbra Group, and EU Ventana Adelante. Her contributions to COVID-19 vaccine research have been recognized in published scientific papers. She has played a key role in Cuban clinical trials for novel immunotherapies and has received funding for advanced research in biotechnology and immunology.

🔍 Research Focus

Camila’s research centers on cancer immunotherapy, focusing on immune checkpoint inhibition and tumor vaccine development. She specializes in recombinant antigen production, immune response characterization, and antibody-based therapies. Her projects involve antigen cloning, protein engineering, and evaluating vaccine efficacy in preclinical models. She has explored the combination of immunotherapies targeting VEGF and PD-L1 pathways to enhance anti-tumor responses. Her work has also contributed to COVID-19 vaccine research, particularly in evaluating immunogenicity and antibody responses.

Conclusion

Camila Canaán-Haden Ayala’s academic and professional trajectory is exceptional, with significant contributions to cancer immunotherapy and vaccine development. Her technical expertise, international exposure, and scientific output make her a strong contender for the Best Researcher Award. With a continued focus on expanding her clinical research impact, publishing in high-impact journals, and taking on leadership roles, her potential to drive groundbreaking innovations is evident.

Publication

M Limonta-Fernández, G Chinea-Santiago, AM Martín-Dunn, …
Title: An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen
Year: 2022
Citation: 63

LA Espinosa, Y Ramos, I Andújar, EO Torres, G Cabrera, A Martín, …
Title: In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2
Year: 2021
Citation: 15

YA Fleites, J Aguiar, Z Cinza, M Bequet, E Marrero, M Vizcaíno, I Esquivel, …
Title: HeberNasvac, a therapeutic vaccine for chronic hepatitis B, stimulates local and systemic markers of innate immunity: Potential use in SARS-CoV-2 postexposure prophylaxis
Year: 2021
Citation: 10

LA Espinosa, Y Ramos, I Andújar, EO Torres, G Cabrera, A Martín, …
Title: In-solution buffer-free digestion for the analysis of SARS-CoV-2 RBD proteins allows a full sequence coverage and detection of post-translational modifications in a single ESI
Year: 2021
Citation: 8

Y Morera-Díaz, C Canaán-Haden, J Sánchez-Ramírez, …
Title: Active immunization with a structurally aggregated PD-L1 antigen breaks T and B immune tolerance in non-human primates and exhibits in vivo anti-tumoral effects in
Year: 2023
Citation: 4

D Vázquez-Blomquist, M Bequet-Romero, Y Mendoza-Marí, G Lemos, …
Title: Nasalferon, a new nasal formulation of IFNα2b, modulates cellular and molecular elements associated with an antiviral response in mucosa and blood
Year: 2022
Citation: 4

EM Idelsis, PE Jésus, DR Yaquelin, VB Dania, BR Mónica, BR Lisandra, …
Title: A combination treatment of IFN-α2b and IFN-γ accelerates viral clearance and control inflammatory response in COVID-19: Preliminary results of a randomized controlled trial
Year: 2021
Citation: 4

C Canaán-Haden, J Sánchez-Ramírez, R Martínez-Castillo, …
Title: Immunogenicity and Safety Profile of Two Adjuvanted-PD-L1-Based Vaccine Candidates in Mice, Rats, Rabbits, and Cynomolgus Monkeys
Year: 2025
Citation: N/A

Y Morera, M Bequet-Romero, F Hernández-Bernal, I González-Moya, …
Title: Preclinical and clinical significance of VEGF deprivation in ovarian cancer through a specific active immunotherapy
Year: 2023
Citation: N/A

Ali Alqudah | Biomedical Engineeringl | Young Scientist Award

Posted on by ScienceFather

Mr. Ali Alqudah | Biomedical Engineeringl | Young Scientist Award

Mr at University of Manitoba, Canada

Ali Mohammad Alqudah, M.Sc., is a dedicated Graduate Research Assistant at the Biomedical Instrumentation and Signal Analysis Lab, Biomedical Engineering Program, University of Manitoba (UoM), Canada. With a strong foundation in computer and biomedical systems engineering, he has contributed significantly to research in machine learning and biomedical applications. Ali is affiliated with multiple professional organizations, including IEEE and ACM, and has been consistently recognized for his academic excellence, notably featuring on Stanford’s top 2% scientist list from 2021 to 2024. His editorial roles in prestigious journals further highlight his expertise and influence in his field. Ali’s research and professional activities reflect his commitment to advancing the integration of AI and biomedical engineering.

Profile

Scopus

Scholar

Education 🎓

Ali Mohammad Alqudah is currently pursuing his Ph.D. in Biomedical Engineering at the University of Manitoba, where he specializes in deep learning applications for medical conditions such as obstructive sleep apnea (OSA). His research under Prof. Zahra Moussavi focuses on innovative diagnostic methods using tracheal breathing sounds during wakefulness. Alqudah’s educational journey began with a B.S.E. in Biomedical Systems Engineering from Yarmouk University, Jordan (2015), followed by an M.Sc. in Computer Engineering (Industrial Automation) in 2018, where he graduated first in his class with a GPA of 91.4%. His academic training includes advanced coursework in biomedical signal processing and medical imaging, shaping his expertise in computational biomedical applications.

 Experience 💼

Ali Mohammad Alqudah’s professional trajectory includes extensive research and teaching experiences. He is currently a Graduate Research Assistant at the University of Manitoba, contributing to cutting-edge studies in biomedical signal processing and AI applications in healthcare. His work has involved deep learning models for OSA detection and other diagnostic innovations. Alqudah’s prior roles include academic assistantships and involvement in laboratory teaching at Yarmouk University. His contributions are marked by the practical integration of machine learning and engineering skills, advancing research that bridges technology and medicine. Ali has also served in editorial capacities for prominent journals, showcasing his thought leadership and commitment to scholarly dissemination.

Awards and Honors 🏆

Ali Mohammad Alqudah’s exceptional contributions have earned him spots on Stanford’s prestigious list of the top 2% of scientists worldwide for four consecutive years (2021-2024). His outstanding academic performance during his M.Sc. at Yarmouk University led to him graduating first in his class. Ali’s scholarly output has been widely recognized, with publications in high-impact journals and conference proceedings. His membership in professional organizations such as IEEE and ACM further testifies to his active engagement in the scientific community. These honors reflect his deep commitment to advancing research in biomedical engineering, signal processing, and artificial intelligence.

Research Focus 🔍

Ali Mohammad Alqudah’s research centers on the intersection of artificial intelligence and biomedical engineering. His primary areas of interest include machine learning and deep learning for medical diagnostics, biomedical signal and image processing, and computer applications in healthcare. His current Ph.D. work explores the application of deep learning for detecting obstructive sleep apnea using non-invasive tracheal breathing sound analysis. Alqudah’s studies incorporate advanced techniques in pattern recognition and AI to improve patient screening and diagnostic accuracy. His commitment to leveraging AI for enhanced medical outcomes positions him as a key contributor to innovations in healthcare technology.

Conclusion 📝

Ali Mohammad Alqudah’s distinguished academic and research career, combined with his technical proficiency and global recognition, make him a strong candidate for the Young Scientist Award. His ongoing work in deep learning for medical diagnostics has the potential to revolutionize early disease detection methods, providing tangible advancements in healthcare technology. With minor enhancements in collaborative and mentorship activities, Alqudah could further solidify his position as a future leader in biomedical engineering research.

Publications 📚

  • Title: Sliding window based deep ensemble system for breast cancer classification
    Year: 2021
    Authors: A Alqudah, AM Alqudah
    Journal: Journal of Medical Engineering & Technology 45 (4), 313-323

 

  • Title: Reduced number of parameters for predicting post-stroke activities of daily living using machine learning algorithms on initiating rehabilitation
    Year: 2021
    Authors: AM Alqudah, M Al-Hashem, A Alqudah
    Journal: Informatica 45 (4)

 

  • Title: Advanced time-frequency methods for ECG waves recognition
    Year: 2023
    Authors: A Zyout, H Alquran, WA Mustafa, AM Alqudah
    Journal: Diagnostics 13 (2), 308

 

  • Title: Pulmonary Diseases Decision Support System Using Deep Learning Approach
    Year: 2022
    Authors: Y Al-Issa, AM Alqudah, H Alquran, A Al Issa
    Journal: Computers, Materials & Continua 73 (1), 311-326

 

  • Title: An embedded system based on raspberry pi for effective electrocardiogram monitoring
    Year: 2023
    Authors: YM Obeidat, AM Alqudah
    Journal: Applied Sciences 13 (14), 8273

 

  • Title: Enhancing Prediction of Prosthetic Fingers Movement Based on sEMG Using Mixtures of Features and Random Forest
    Year: 2019
    Authors: WN Al-Sharu, AM Alqudah
    Journal: International Journal of Recent Technology and Engineering (IJRTE) 8 (4)

 

  • Title: International Journal of Advanced Trends in Computer Science and Engineering
    Year: 2019
    Authors: AM Alqudah, H Alquraan, IA Qasmieh, A Alqudah, W Al-Sharu
    Journal: International Journal 8 (6)

 

  • Title: EOG-based mouse control for people with quadriplegia
    Year: 2016
    Author: AM Alqudah
    Journal: XIV Mediterranean Conference on Medical and Biological Engineering and …

 

  • Title: A New Weighted Deep Learning Feature Using Particle Swarm and Ant Lion Optimization for Cervical Cancer Diagnosis on Pap Smear Images
    Year: 2023
    Authors: M Alsalatie, H Alquran, WA Mustafa, A Zyout, AM Alqudah, R Kaifi, …
    Journal: Diagnostics 13 (17), 2762

 

  • Title: The Internet of Things in Healthcare: A survey for Architecture, Current and Future Applications, Mobile Application, and Security
    Year: 2019
    Author: AM Alqudah
    Journal: JOIV: International Journal on Informatics Visualization 3 (2), 113-122

 

  • Title: Detection of valvular heart diseases using fourier transform and simple cnn model
    Year: 2022
    Authors: WN Al-Sharu, AM Alqudah, S Qazan, A Alqudah
    Journal: IAENG International Journal of Computer Science 49 (4), 985-993

 

  • Title: Automated diagnosis of heart-lung diseases in chest X-ray images
    Year: 2022
    Authors: M Alslatie, H Alquran, WA Mustafa, I Abu-Qasmieh, AM Alqudah, …
    Journal: 2022 5th International Conference on Engineering Technology and its …

 

Kyu Sik Kim| Medicine | Young Scientist Award

Posted on by ScienceFather

Mr. Kyu Sik Kim| Medicine | Young Scientist Award

Mr at Seoul National University, South Korea

Kyu Sik Kim is a dedicated PhD candidate at Seoul National University, specializing in systems neuroscience. His research focuses on how the hypothalamus regulates feeding behavior and seeks to bridge the gap between animal and human studies. Passionate about improving therapeutic outcomes, he aims to translate his findings into better treatment options.

 

Publication profile

Scopus

Orcid

Scholar

🎓 Education & Training

M.S./Ph.D. Candidate in Biomedical Science, Seoul National University, College of Medicine (2020–Present) Advisor: Prof. Hyung Jin Choi. B.S. in Life Science, Sogang University, Seoul, Korea (2014-2018)

🔬 Major Research Interests

Brain activity and ethology analysis with artificial intelligence. Internal state changes in the brain. Competing needs and motivation in the brain. Hypothalamic neuronal circuits in emotion and eating. Translational research and clinical applications

🏆 Honors, Funding & Awards

2024: 2-year research program (48M Won) for cultivating future generations in science and engineering. 2024: Basic Academic Field Academic Subsequent Generation (24M Won). 2024: Optodbs Travel Grant. Multiple prizes for Outstanding Graduate Student at Seoul National University (2023-2024). Best Paper Award (March-May 2023)

🛠 Skills & Professional Expertise

Software Tools: Ethovision, Inscopix Data Processing, MATLAB, Python. Experimental Techniques: Immunocytochemistry, stereotaxic surgery, animal behavior experiments, and fMRI imaging. Teaching & Mentoring: Guided students in medical research programs at Seoul National University

Publication

  • Lateral Hypothalamic Leptin Receptor Neurons Drive Hunger-Gated Food-Seeking and Consummatory Behaviours in Male Mice
    • Authors: Y.H. Lee, Y.B. Kim, K.S. Kim, M. Jang, H.Y. Song, S.H. Jung, D.S. Ha, J.S. Park, …
    • Published In: Nature Communications, 14(1), 1486
    • Citations: 19
    • Year: 2023

 

  • GLP-1 Increases Preingestive Satiation via Hypothalamic Circuits in Mice and Humans
    • Authors: K.S. Kim, J.S. Park, E. Hwang, M.J. Park, H.Y. Shin, Y.H. Lee, K.M. Kim, L. Gautron, …
    • Published In: Science, 385(6707), 438-446
    • Citations: 6
    • Year: 2024

 

  • Acoustic Deep Brain Modulation: Enhancing Neuronal Activation and Neurogenesis
    • Authors: H. Ham, K.S. Kim, J.H. Lee, D.N. Kim, H.J. Choi, J.J. Yoh
    • Published In: Brain Stimulation
    • Year: 2024

 

  • A Normative Framework Dissociates Need and Motivation in Hypothalamic Neurons
    • Authors: K.S. Kim, Y.H. Lee, Y.B. Kim, J.W. Yun, H.Y. Song, J.S. Park, S.H. Jung, J.W. Sohn, …
    • Published In: bioRxiv
    • Year: 2023

 

Haseeb Sattar | Clinical Medicine | Best Faculty Award

Posted on by ScienceFather

Assoc Prof Dr. Haseeb Sattar | Clinical Medicine  | Best Faculty Award

Assoc Prof Dr Haseeb Sattar Urban Vocational College of Sichuan Chengdu China

Dr. Haseeb Sattar is a seasoned medical professional with extensive experience in clinical pharmacotherapy and internal medicine. He holds a PhD in Clinical Pharmacology from Huazhong University of Science and Technology, China, and has served as an Assistant Professor at several prestigious universities in China, teaching clinical subjects to international MBBS students. Dr. Sattar has a strong background in research, with numerous publications in leading medical journals. His career is distinguished by his commitment to medical education, research, and patient care, making him a valuable asset to any academic or clinical institution.

Publication profile

Scopus

Scholar

🎓 Education

PhD/DM in Clinical Pharmacology-Clinical Pharmacy – Tongji Medical College of Huazhong University of Science and Technology, China. Dates: September 2014 – June 2017. PG-Dip in Internal Medicine – University of Edinburgh, UK Dates: September 2018 – August 2020. MPhil in Medical Microbiology – Quaid-i-Azam University, Islamabad, Pakistan Dates: January 2012 – 2014. Doctor of Pharmacy (PharmD) – Riphah International University, Islamabad, Pakistan Dates: September 2005 – August 2010. Higher Secondary School Certificate (HSSC) – Federal Board of Intermediate & Secondary Education, Islamabad, Pakistan. Dates: August 2002 – August 2004. Diploma in Computer Hardware – Super Tech Institute of Computer Sciences Dates: May 2002 – August 2002. Secondary School Certificate (SSC) – Federal Board of Intermediate & Secondary Education, Islamabad, Pakistan Dates: March 2000 – March 2002

👨‍🏫 Professional Experience

Assistant Professor of Medicine – Chengdu University of TCM, Chengdu, China Dates: September 2019 – Present Responsibilities: Teaching clinical subjects to foreign MBBS students. Assistant Professor of Medicine – Hubei University of Traditional Chinese Medicine, Wuhan, China Dates: September 2017 – July 2019 Responsibilities: Teaching clinical subjects to foreign MBBS students. Lecturer (Part-Time) – Hubei University of Nationality, Enshi, China Dates: July 2016 – July 2017. Responsibilities: Teaching internal medicine, diagnostics, pharmacology, preventive medicine, and infectious diseases. Lecturer of Clinical Pharmacotherapeutics and Clinical Practices – University of Lahore, Islamabad Campus Dates: September 2010 – September 2014 Responsibilities: Taking lectures, hospital ward rounds.

🏅 Certifications

American Board Certification in Pharmacotherapy (BCPS), USA. American Board-Certified Cardiology Specialist (BCCP). Certification in Toxicology, Harvard Medical University, USA. Certification in Endocrine Emergencies, Harvard Medical University, USA. Certification in COPD Management, University of Pennsylvania School of Medicine, USA

📝 Research Publications

Sattar, Haseeb, et al. “Role of glucuronidation pathway in quetiapine metabolism: An in vivo drug–drug interaction study between quetiapine and probenecid.” Saudi Journal of Medicine & Medical Sciences, 2020. Nie Q, Sattar H, et al. “An intramural left ventricular fistula caused by left ventriculography.” World Journal of Emergency Medicine, 2022. Luo Y, Jiang Q, Zhu Z, Sattar H, et al. “Phosphoproteomics and proteomics reveal metabolism as a key node in LPS-induced acute inflammation in RAW264. 7.” Inflammation, 2020.

🏆 Achievements

Recipient of the Chinese Government Scholarship. Multiple scholarships during university (Mumtaz Scholarships)

Evaluation for Best Faculty Award 🏆

Strengths for the Award:

Extensive Clinical and Academic Experience: Dr. Haseeb Sattar has over a decade of experience in clinical pharmacotherapy and internal medicine, with a strong foundation in both practical and theoretical aspects of the field. His roles in various academic institutions, particularly in teaching clinical subjects to MBBS students, demonstrate his commitment to education and student development. Diverse Educational Background: Dr. Sattar’s qualifications, including a Doctor of Pharmacy (PharmD), MPhil in Medical Microbiology, and PhD/DM in Clinical Pharmacology, provide him with a broad and in-depth understanding of medicine. His postgraduate diploma in Internal Medicine from the University of Edinburgh further solidifies his expertise. Research Accomplishments: With numerous publications in reputable journals, Dr. Sattar has contributed significantly to medical research. His work spans various topics, including pharmacotherapy, clinical pharmacy, and internal medicine, reflecting his active engagement in advancing medical knowledge. International Exposure: Dr. Sattar’s teaching and research experiences across Pakistan and China, coupled with certifications from prestigious institutions in the USA, highlight his global perspective and adaptability in different educational and healthcare environments. Recognition and Awards: Dr. Sattar has been the recipient of multiple scholarships, including the prestigious Chinese Government Scholarship, which underscores his academic excellence and recognition by international bodies.

Areas for Improvement:

Focused Research Themes: While Dr. Sattar has published extensively, focusing on a more specific research theme or developing a specialized niche could enhance his recognition in a particular area of medicine. Increased Collaboration: Engaging in more collaborative research with other international institutions and experts could further elevate his profile and contribute to broader scientific advancements. Leadership Roles: Taking on more leadership roles in academic or research institutions could showcase his ability to influence and guide future research directions and academic programs.

Publication top notes

  • Reactive Oxygen Species‐Mediated Tumor Microenvironment Transformation: The Mechanism of Radioresistant Gastric Cancer
    • Journal: Oxidative Medicine and Cellular Longevity
    • Year: 2018
    • DOI: 10.1155/2018/5801209
    • Contributors: H. Gu, T. Huang, Y. Shen, Y. Liu, F. Zhou, Y. Jin, H. Sattar, Y. Wei
    • Citations: 64

 

  • Co-existence of blaNDM-1 and blaKPC-2 in Clinical Isolates of Klebsiella pneumoniae from Pakistan
    • Journal: Journal of Chemotherapy
    • Year: 2016
    • Volume: 28(4), 346-349
    • Contributors: H. Sattar, M. Toleman, F. Nahid, R. Zahra
    • Citations: 35

 

  • The Prognostic Value of Long Noncoding RNAs in Prostate Cancer: A Systematic Review and Meta-Analysis
    • Journal: Oncotarget
    • Year: 2017
    • Volume: 8(34), 57755
    • Contributors: W. Ma, X. Chen, L. Ding, J. Ma, W. Jing, T. Lan, H. Sattar, Y. Wei, F. Zhou
    • Citations: 24

 

  • Natural Killer Cell Immunotherapy Against Multiple Myeloma: Progress and Possibilities
    • Journal: Journal of Leukocyte Biology
    • Year: 2018
    • Volume: 103(5), 821-828
    • Contributors: P. Liu, Y. Jin, H. Sattar, H. Liu, W. Xie, F. Zhou
    • Citations: 18

 

Conclusion:

Dr. Haseeb Sattar’s extensive clinical experience, robust academic background, and significant research contributions make him a strong candidate for the Best Faculty Award. His diverse expertise and international exposure, combined with his dedication to education and research, position him as an exemplary figure in the field of medicine. With a focus on further specialization and increased collaborative efforts, Dr. Sattar’s impact on the medical community is likely to grow, making him well-deserving of this recognition.